06425006 · Active · incorporated 18 years, 8 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Crescendo Biologics develops novel T cell enhancing therapeutics for immuno-oncology, focusing on Humabody® VH therapeutics.
https://www.crescendobiologics.com/
See the complete cap table with every shareholder, founder tags, dilution across 58 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.